ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,319Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 1107

$1.06M Total Retail Price of All Prescriptions

Rank: 80 out of 1107

589 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 589 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

36% of this provider’s 589 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 17,796 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 972 568 S3 1 1
FUROSEMIDE 910 771 2 7
LEVOTHYROXINE SODIUM 797 583 3 3
OMEPRAZOLE 727 555 4 4
POTASSIUM CHLORIDE 704 515 5 14
WARFARIN SODIUM 643 549 6 15
ATENOLOL 562 464 7 19
NEXIUM 459 322 8 18
SIMVASTATIN 409 311 9 5
MELOXICAM 368 266 10 25
PRAVASTATIN SODIUM 328 271 11 12
LISINOPRIL 321 224 12 2
TAMSULOSIN HCL 300 261 13 30
SERTRALINE HCL 298 226 14 20
METFORMIN HCL 287 197 15 8
AMLODIPINE BESYLATE 268 231 16 6
CRESTOR 244 178 17 23
METOPROLOL TARTRATE 243 178 18 10
CITALOPRAM HBR 239 159 19 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 227 171 20 24
PANTOPRAZOLE SODIUM 216 188 21 30
NAPROXEN 213 135 22 80
HYDROCHLOROTHIAZIDE 212 150 23 11
CARVEDILOL 211 199 24 27
GABAPENTIN 208 91 25 9
CLOPIDOGREL 206 143 26 28
ATORVASTATIN CALCIUM 195 150 27 13
CLONIDINE HCL 178 111 28 53
BUMETANIDE 176 129 29 123
DICLOFENAC SODIUM 173 135 30 74
PAROXETINE HCL 169 116 31 45
LOSARTAN POTASSIUM 168 100 32 29
METOPROLOL SUCCINATE 166 120 33 16
GLIMEPIRIDE 161 134 34 43
DIGOXIN 153 151 35 52
ENALAPRIL MALEATE 138 112 36 98
NAMENDA 136 136 37 42
SULINDAC 133 85 38 224
ISOSORBIDE MONONITRATE ER 132 110 39 34
POLYETHYLENE GLYCOL 3350 132 116 39 46
SUCRALFATE 130 73 41 121
ALLOPURINOL 126 102 42 36
LOSARTAN-HYDROCHLOROTHIAZIDE 126 78 42 66
CELEBREX 125 92 44 85
CIPROFLOXACIN HCL 125 101 44 59
BISOPROLOL FUMARATE 124 115 46 136
ACETAMINOPHEN-CODEINE 121 90 S3 47 120
MUPIROCIN 121 107 47 161
ROPINIROLE HCL 121 103 47 69
AZITHROMYCIN 119 60 50 35
NYSTATIN 118 90 51 110
PENTOXIFYLLINE 117 93 52 341
ZOLPIDEM TARTRATE 117 77 52 22
CILOSTAZOL 114 93 54 194
PLAVIX 113 82 55 39
TRAZODONE HCL 113 70 55 33
CYCLOBENZAPRINE HCL 112 45 R 57 56
SINGULAIR 111 99 58 65
LEVOFLOXACIN 110 84 59 71
MECLIZINE HCL 110 107 59 114
IBUPROFEN 109 47 61 63
TIZANIDINE HCL 108 37 62 73
DIPYRIDAMOLE 108 52 R 62 316
ENDOCET 108 47 S2 62 91
PREDNISONE 108 65 62 40
GEMFIBROZIL 107 82 66 107
TRAMADOL HCL 106 88 67 26
DONEPEZIL HCL 104 104 68 32
NABUMETONE 102 63 69 181
THEOPHYLLINE ANHYDROUS 100 81 70 158
VENLAFAXINE HCL ER 100 44 70 117
AMITRIPTYLINE HCL 99 49 R 72 48
RANITIDINE HCL 98 49 73 21
FINASTERIDE 94 87 74 130
SPIRONOLACTONE 93 78 75 72
PROPRANOLOL HCL 90 62 76 134
ALPRAZOLAM 88 56 77 87
PHENYTOIN SODIUM EXTENDED 88 34 77 147
DILTIAZEM ER 88 46 77 139
COLCRYS 86 72 80 233
HYDRALAZINE HCL 82 65 81 99
JANUVIA 80 63 82 60
AMIODARONE HCL 79 70 83 199
MONTELUKAST SODIUM 78 65 84 118
EXELON 78 71 84 103
CEPHALEXIN 78 53 84 81
KETOPROFEN 78 60 84 301
PROMETHAZINE HCL 71 19 R 88 44
ZETIA 71 66 88 76
TRIAMCINOLONE ACETONIDE 70 47 90 137
FLUTICASONE PROPIONATE 70 53 90 38
TERAZOSIN HCL 70 55 90 173
NITROSTAT 67 57 93 188
FENTANYL 67 66 S2 93 105
ALENDRONATE SODIUM 67 42 93 41
LANTUS SOLOSTAR 66 66 96 129
TRILIPIX 66 52 96 153
DIOVAN 65 41 98 51
GLYBURIDE 64 54 R 99 68
PREMARIN 63 32 R 100 149
BENZTROPINE MESYLATE 63 51 R 100 174
ADVAIR DISKUS 63 42 100 54
SYMBICORT 61 33 103 124
BISOPROLOL-HYDROCHLOROTHIAZIDE 59 56 104 164
DIOVAN HCT 58 55 105 106
NITROGLYCERIN PATCH 58 58 105 184
BENAZEPRIL HCL 56 43 107 86
VENLAFAXINE HCL 55 15 108 193
LANSOPRAZOLE 54 50 109 102
SYNTHROID 54 54 109 70
FLUCONAZOLE 54 29 109 150
GLYBURIDE-METFORMIN HCL 52 50 R 112 165
NIASPAN 51 31 113 125
AMLODIPINE BESYLATE-BENAZEPRIL 51 33 113 77
CYMBALTA 51 0 113 50
CIMETIDINE 50 22 116 479
ONGLYZA 50 36 116 205
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.